BOULDER, Colo., May 8 /PRNewswire-FirstCall/ -- Tapestry Pharmaceuticals, Inc. announced today that management will provide a company update at the Acumen BioFion Rodman & Renshaw 4th Annual Global Healthcare Conference on May 15, 2007 at 9:00 a.m. Central European Summer Time (3:00 a.m. Eastern Daylight Time). The conference is being held at Le Meridien Beach Plaza Hotel in Monte Carlo, Monaco. A live audio webcast of the call will be available on the "Investors" section of the Company's website, http://www.tapestrypharma.com. The audio webcast will not be archived.
About Tapestry Pharmaceuticals, Inc.
Tapestry Pharmaceuticals, Inc. is a biopharmaceutical company focused on the development of proprietary therapies for the treatment of cancer. For more information about Tapestry and its technologies, visit Tapestry's website at http://www.tapestrypharma.com.
Contact: Tapestry Pharmaceuticals, Inc. Gordon Link Senior Vice President, Chief Financial Officer 303-516-8500 glink@tapestrypharma.com Investor: Lilian Stern Stern Investor Relations, Inc. 212-362-1200 lilian@sternir.com Media: Dana Conti Schwartz Communications, Inc. 781-684-0770 tapestry@schwartz-pr.com
Tapestry Pharmaceuticals, Inc.CONTACT: Gordon Link, Senior Vice President, Chief Financial Officer ofTapestry Pharmaceuticals, Inc., +1-303-516-8500, glink@tapestrypharma.com;or Investor: Lilian Stern of Stern Investor Relations, Inc.,+1-212-362-1200, lilian@sternir.com; or Media: Dana Conti of SchwartzCommunications, Inc., +1-781-684-0770, tapestry@schwartz-pr.com
Web site: http://www.tapestrypharma.com/
